Details for New Drug Application (NDA): 209314
✉ Email this page to a colleague
The generic ingredient in POTASSIUM CHLORIDE is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.
Summary for 209314
Tradename: | POTASSIUM CHLORIDE |
Applicant: | Yichang Humanwell |
Ingredient: | potassium chloride |
Patents: | 0 |
Pharmacology for NDA: 209314
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 209314
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 209314 | ANDA | Epic Pharma, LLC | 42806-422 | 42806-422-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42806-422-01) |
POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 209314 | ANDA | Epic Pharma, LLC | 42806-422 | 42806-422-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42806-422-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 8MEQ | ||||
Approval Date: | Jun 22, 2018 | TE: | AB2 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
Approval Date: | Jun 22, 2018 | TE: | AB2 | RLD: | No |
Complete Access Available with Subscription